Skip to content
FORSIDEN
Log ind Opret konto
  • Kategorier
  • Seneste
  • Etiketter
  • Populære
  • Verden
  • Bruger
  • Grupper
Temaer
  • Light
  • Brite
  • Cerulean
  • Cosmo
  • Flatly
  • Journal
  • Litera
  • Lumen
  • Lux
  • Materia
  • Minty
  • Morph
  • Pulse
  • Sandstone
  • Simplex
  • Sketchy
  • Spacelab
  • United
  • Yeti
  • Zephyr
  • Dark
  • Cyborg
  • Darkly
  • Quartz
  • Slate
  • Solar
  • Superhero
  • Vapor

  • Default (No Skin)
  • No Skin
Kollaps
  1. Debatforum
  2. Kategorier
  3. Hansa Biopharma
  4. Hansa Biopharma — Oktober 2024

Hansa Biopharma — Oktober 2024

Planlagt Fastgjort Låst Flyttet Hansa Biopharma
93 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • exitnuE Offline
    exitnuE Offline
    exitnu
    wrote on sidst redigeret af
    #3

    God morgen 🙂

    1 Reply Last reply
    0
    • exitnuE Offline
      exitnuE Offline
      exitnu
      wrote on sidst redigeret af
      #4

      Hansa Biopharma AB: Hansa Biopharma bjuder in till en telefonkonferens för att presentera delårsrapporten för Q3 2024

      Link Preview Image
      Hansa Biopharma bjuder in till en telefonkonferens för att presentera delårsrapporten för Q3 2024

      Lund, Sverige, den 3 oktober 2024. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA)

      favicon

      News Powered by Cision (news.cision.com)

      .. Hansa Biopharma AB, “Hansa” (Nasdaq Stockholm: HNSA) offentliggör sin delårsrapport för januari-september 2024 den 17 oktober 2024. ..

      1 Reply Last reply
      0
      • exitnuE Offline
        exitnuE Offline
        exitnu
        wrote on sidst redigeret af
        #5

        Mærkeligt, jeg har haft den 24. oktober stående "i min kalender" i rigtig lang tid, følgende har også fremgået fra hjemmesiden: "Upcoming events. 24. Oct. Interim Report for January-September 2024".

        1 Reply Last reply
        0
        • exitnuE Offline
          exitnuE Offline
          exitnu
          wrote on sidst redigeret af
          #6

          ".. och en uppdatering av verksamheten .." måske at datoen er blevet fremrykket for at give plads for en nyhed eller to ...

          1 Reply Last reply
          0
          • exitnuE Offline
            exitnuE Offline
            exitnu
            wrote on sidst redigeret af
            #7

            Blot et gæt: det må være positivt når der er tale om en fremrykning. Fx noget omkring strategiske overvejelser (markedstiming), gode resultater eller fremskridt ...

            1 Reply Last reply
            0
            • L Offline
              L Offline
              LP90
              wrote on sidst redigeret af
              #8

              exitnu ja det bliver spændende og oftest er en fremrykning gode tegn 🙂

              1 Reply Last reply
              0
              • R Offline
                R Offline
                radar24
                wrote on sidst redigeret af
                #9

                Hvis der er kendte afgørende nyheder skal de komme med det samme,så det er det jo nok ikke.. Jeg har forlængst mistet tålmodigheden med denne aktie, og bliver tidligst aktionær når ledelsen er udskiftet og selskabet har positiv cashflow!!!!

                1 Reply Last reply
                0
                • L Offline
                  L Offline
                  LP90
                  wrote on sidst redigeret af
                  #10

                  Godmorgen 🙂 radar jeg er enig med dig jeg har længe som i længe klandret ledelsen for
                  mangel på fremdrift med salget/partner aftaler samt et alt for stor cash burn

                  1 Reply Last reply
                  0
                  • L Offline
                    L Offline
                    LP90
                    wrote on sidst redigeret af
                    #11

                    Godmorgen 🙂

                    1 Reply Last reply
                    0
                    • exitnuE Offline
                      exitnuE Offline
                      exitnu
                      wrote on sidst redigeret af
                      #12

                      God morgen 🙂

                      1 Reply Last reply
                      0
                      • exitnuE Offline
                        exitnuE Offline
                        exitnu
                        wrote on sidst redigeret af
                        #13

                        Hansa Biopharmas meddelar positiva resultat från HNSA-5487

                        1 Reply Last reply
                        0
                        • exitnuE Offline
                          exitnuE Offline
                          exitnu
                          wrote on sidst redigeret af
                          #14

                          Hansa Biopharma’s HNSA-5487 Achieved Rapid and Highly Robust IgG Reduction by More Than 95% and Clear Redosing Potential in First-in-Human Trial

                          Link Preview Image
                          Hansa Biopharma’s HNSA-5487 Achieved Rapid and Highly Robust IgG Reduction by More Than 95% and Clear Redosing Potential in First-in-Human Trial | Hansa Biopharma

                          favicon

                          (www.hansabiopharma.com)

                          1 Reply Last reply
                          0
                          • exitnuE Offline
                            exitnuE Offline
                            exitnu
                            wrote on sidst redigeret af
                            #15

                            Søren Tulstrup, President and CEO, Hansa Biopharma said, “There is mounting clinical evidence that faster and more robust IgG reduction is directly linked to more successful therapeutic outcomes in autoimmune and other diseases. We are very encouraged by these results that demonstrate HNSA-5487 can robustly and very rapidly reduce IgG levels, has redosing potential, and a favorable safety and tolerability profile. ...

                            1 Reply Last reply
                            0
                            • exitnuE Offline
                              exitnuE Offline
                              exitnu
                              wrote on sidst redigeret af
                              #16

                              ... We believe HNSA-5487 has a highly differentiated profile compared to published data from studies with other IgG-targeted therapies. These results underscore the transformational potential of HNSA-5487 to address significant unmet need across a spectrum of IgG driven diseases and conditions, including autoimmune where there is a clear need for better management of initial and repeat immune system attacks.”

                              1 Reply Last reply
                              0
                              • exitnuE Offline
                                exitnuE Offline
                                exitnu
                                wrote on sidst redigeret af
                                #17

                                "Hansa Biopharma AB: Hansa Biopharmas HNSA-5487 uppnådde en snabb och mycket robust IgG-reduktion med mer än 95 procent i den första kliniska studien, och uppvisar en tydlig potential för återdosering"

                                1 Reply Last reply
                                0
                                • exitnuE Offline
                                  exitnuE Offline
                                  exitnu
                                  wrote on sidst redigeret af
                                  #18

                                  Hansa Biopharma Pipeline: https://www.hansabiopharma.com/our-science/pipeline

                                  1 Reply Last reply
                                  0
                                  • exitnuE Offline
                                    exitnuE Offline
                                    exitnu
                                    wrote on sidst redigeret af
                                    #19

                                    Hansa Biopharma will host a telephone conference on 7 October at 14:00 CET / 8:00 AM EST.

                                    Slides used in the presentation will be available online following the call.

                                    Join the webcast here: https://event.choruscall.com/mediaframe/webcast.html?webcastid=6iGh9S4f

                                    1 Reply Last reply
                                    0
                                    • exitnuE Offline
                                      exitnuE Offline
                                      exitnu
                                      wrote on sidst redigeret af
                                      #20

                                      Startet 🙂

                                      1 Reply Last reply
                                      0
                                      • exitnuE Offline
                                        exitnuE Offline
                                        exitnu
                                        wrote on sidst redigeret af
                                        #21

                                        Spændende om der måske kommer nye kursmål de kommende dage/uger .. 🙂

                                        1 Reply Last reply
                                        0
                                        • exitnuE Offline
                                          exitnuE Offline
                                          exitnu
                                          wrote on sidst redigeret af
                                          #22

                                          Hansa Biopharma: NiceR is in a good position to expand the future market

                                          Just a moment...

                                          favicon

                                          (www.redeye.se)

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind
                                          Svar
                                          • Svar som emne
                                          Login for at svare
                                          • Ældste til nyeste
                                          • Nyeste til ældste
                                          • Most Votes


                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          Powered by NodeBB Contributors
                                          • First post
                                            Last post
                                          0
                                          • Kategorier
                                          • Seneste
                                          • Etiketter
                                          • Populære
                                          • Verden
                                          • Bruger
                                          • Grupper